M&A Deal Summary |
|
|---|---|
| Date | 2006-04-13 |
| Target | Watson Pharma Private |
| Sector | Healthcare Services |
| Buyer(s) | Allergan |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1956 |
| Sector | Life Science |
| Employees | 31,200 |
| Revenue | 15.8B USD (2018) |
Allergan is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company was originally established in 1956 and is based in Parsippany, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 38 |
| Sector (Healthcare Services) | 2 of 2 |
| Type (Add-on Acquisition) | 3 of 31 |
| Country (India) | 1 of 1 |
| Year (2006) | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2000-08-28 |
Watson Pharmaceuticals
Florham Park, New Jersey, United States Watson Pharmaceuticals, Inc.,is a specialty pharmaceutical company that develops, manufactures, markets and distributes branded and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-11-06 |
Andrx
Davie, Florida, United States Andrx Corporation is engaged in the formulation and commercialization of oral controlled-release pharmaceuticals utilizing its proprietary drug delivery technologies. In its ANDA program, Andrx is developing bio-equivalent or generic versions of selected high sales volume controlled-release brand name pharmaceuticals. |
Buy | - |
